🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Cutaneous Angiosarcoma

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma NCT07655570Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ivonescimab Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients NCT06673628Phase 26 sites📍 Kashiwa📍 Kyoto📍 Miyazaki National Cancer Center, Japan · Tests: Pembrolizumab plus Lenvatinib A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MQ719, Pembrolizumab Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma NCT07007273Phase 23 sites📍 Tampa📍 Columbus📍 Houston H. Lee Moffitt Cancer Center and Research Institute · Tests: Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy